- Revenue potential
- Leadership team
- Brand/product traction
- Competitive landscape
Additionally, all companies must be independent (unacquired), privately owned, at most 10 years old, and have received at least one round of funding in order to qualify.
Looking for a badge to celebrate your awesome accomplishment? Find it here!
“Pillar Biosciences aims to “Make Precision Medicine Accessible” by developing and manufacturing targeted next-generation sequencing (NGS)-based assays and software for today’s high-throughput specialty NGS laboratories.
Through our SLIMamp technology (a multiplex overlapping PCR chemistry) Pillar offers a streamlined, robust and economical workflow with high mapping and on-target metrics.
In conjunction with the SLIMamp assay technology, Pillar Biosciences has an informatics pipeline called the Pillar Variant Analysis Toolkit (PiVAT) that is not only highly accurate, enabling somatic variant calls down to 1% allele frequency without use of Unique Identifiers (UIDs), but also fast and efficient, returning valuable sample data quickly.”
“Attestiv puts authenticity back into photo and media files, utilizing advanced technologies in mobile, AI and blockchain. Attestiv products create new efficiencies, offer unrivaled fraud prevention and maintain interoperability with existing infrastructure.”